Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBBQ vs. RYOIX: which is better?

Bottom line

IBBQ vs RYOIX: the short answer

IBBQ (Invesco Nasdaq Biotechnology ETF) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 58% by weight.

But IBBQ is far broader, holding 261 positions to 74 for RYOIX, so beyond the top names it adds exposure RYOIX doesn't have.

IBBQ is cheaper at 0.19% vs 1.38% — a difference of $119 a year per $10,000 invested.

Over one year, RYOIX returned +30.7% vs −0.6% for IBBQ (reporting dates differ).

Updated Nov 19, 2026

IBBQ vs RYOIX side by side

IBBQRYOIX
TypeETFMutual fund
Fund familyInvescoGuggenheim
CategoryTechnology SectorTechnology Sector
Expense ratio0.19%1.38%
Annual cost per $10k$19$138
10-yr cost on $10k (prospectus)$242$1,709
Max front loadNone—
12b-1 fee—0%
1-yr return−0.6%+30.7%
5-yr return (annualized)—+4.0%
10-yr return (annualized)—+5.9%
Best quarter+12.0%+28.3%
Worst quarter−11.7%−22.5%
Net assets (fund)$67.4M$136.8M
Number of holdings26174
Portfolio turnover17%75%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBQRYOIXDifference
2024−0.6%−0.7%+0.1%
2023+4.5%+6.1%−1.6%
2022−10.2%−13.1%+2.8%

Source: Fund prospectus bar charts

Holdings overlap

17 of IBBQ's top 25 holdings also appear in RYOIX's top 25.

Shared top holdings
HoldingIBBQRYOIX
Gilead Sciences, Inc.7.39%4.49%
Vertex Pharmaceuticals Inc.7.38%4.32%
Amgen Inc.7.10%5.05%
Regeneron Pharmaceuticals, Inc.5.08%2.93%
Alnylam Pharmaceuticals, Inc.3.19%2.36%
Revolution Medicines, Inc.2.48%2.48%
Biogen Inc.2.29%2.13%
Illumina, Inc.1.98%1.94%
United Therapeutics Corp.1.94%1.72%
argenx SE1.89%1.48%
Insmed Inc.1.83%1.79%
Incyte Corp.1.53%1.62%
Viatris Inc.1.49%1.55%
Moderna, Inc.1.48%2.15%
Guardant Health, Inc.1.35%1.72%

Source: SEC Form N-PORT

IBBQ top 10

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Vertex Pharmaceuticals Inc. — 7.38%
  4. Amgen Inc. — 7.10%
  5. Invesco Private Government Fund — 5.48%
  6. Regeneron Pharmaceuticals, Inc. — 5.08%
  7. Alnylam Pharmaceuticals, Inc. — 3.19%
  8. Revolution Medicines, Inc. — 2.48%
  9. Biogen Inc. — 2.29%
  10. Illumina, Inc. — 1.98%

RYOIX top 10

  1. Abbvie Inc — 8.17%
  2. Amgen Inc — 5.05%
  3. Gilead Sciences Inc — 4.49%
  4. Vertex Pharmaceuticals Inc — 4.32%
  5. Regeneron Pharmaceuticals Inc — 2.93%
  6. Revolution Medicines Inc — 2.48%
  7. Alnylam Pharmaceuticals Inc — 2.36%
  8. Beone Medicines Ltd — 2.17%
  9. Moderna Inc — 2.15%
  10. Biogen Inc — 2.13%

FAQ

What is the difference between IBBQ and RYOIX?
IBBQ (Invesco Nasdaq Biotechnology ETF) and RYOIX (Biotechnology Fund) share a meaningful slice of their top holdings — about 58% by weight. But IBBQ is far broader, holding 261 positions to 74 for RYOIX, so beyond the top names it adds exposure RYOIX doesn't have.
Which is cheaper, IBBQ or RYOIX?
IBBQ has the lower expense ratio (0.19%).
Should I own both IBBQ and RYOIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.